N@N

Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $7 on, May 15th, 2024

Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, May 15th, 2024.

Gil has made no other calls on TSHA in the last 4 months.

There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.

These are the ratings of the 5 analyists that currently disagree with Gil

---

• Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
• Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
• Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
• Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Increased Target to $7 on, Thursday, March 21st, 2024
• Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024

Contributing Sources

---